Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02353078 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02353078: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT02353078 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02353078, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?
Interventions
- DRUG Sucralfate
- PROCEDURE Intraluminal Impedance
- DEVICE Intraluminal Impedance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02353078
The ClinicalTrials.gov registry entry for NCT02353078 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sucralfate is the first listed.
NCT02353078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02353078 about?
NCT02353078 is a clinical study titled "The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis". Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?
What is the current status of trial NCT02353078?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2015-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02353078?
The interventions under investigation include: Sucralfate (DRUG), Intraluminal Impedance (PROCEDURE), Intraluminal Impedance (DEVICE).
Who is sponsoring clinical trial NCT02353078?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.